Cardiovascular measures included cardiometabolic biomarkers such as C-reactive protein (CRP), [22, 29] hypertension/blood pressure, [23, 29, 33, 52, 64] and having either a history of or dying from heart disease. This evidence concerns the gene CRP and heart disorder.